FIELD OF INVENTION

The present disclosure relates to a method of treating an infection in humans, and more particularly, the present invention relates to a method of treating infections and its associated complications and pathophysiological conditions in humans, including Covid19.

BACKGROUND

All living organisms have some sort of immune system to fight pathogenic microorganisms. Humans have multiple defenses against pathogenic microorganisms including bacteria, viruses, and fungi. However, the natural defenses are not always adequate, and the patient requires external support to combat the infection. For example, the white blood cells called lymphocytes of the immune system defend against viral infections. However, in the case of novel viruses, the defensive lymphocytes are initially low in number and it may take days to proliferate to effective numbers that can fight the infection. Moreover, the human defense system may fail against both the known and new types of infection. Thus, external support to combat the infections become essential. The external support can be one that directly kills or prevent the growth of microorganism, such as antibiotics. Or the external support can be supportive, for example, ventilation, hydration, and nourishing the body.

With the increasing occurrences of new forms of pathogens and increasing resistance against the known, a need is always there for more effective means to counter the infections.

SUMMARY OF THE INVENTION

The principal object of the present invention is to cure the viral infection at all stage of infection.

It is another object of the present invention to reduce complications associated with viral infection.

It is still another object of the present invention to prevent the replication of the viruses in the human body.

It is yet another object of the present invention to improve oxygen uptake by the lungs.

In one aspect, disclosed is a method of treating viral infections in humans. The method comprising administering to a patient a composition of dextrose and ethanol. The composition can be administered in the form of an infusion.

In one aspect, the method comprises administrating a 5%-10% alcohol in 5% dextrose sterile, nonpyrogenic, hypertonic solution and special cool inhaler alcohol with Methylene blue.

In one aspect, disclosed is a method to enhance oxygen uptake in a patient on a ventilator. The method includes the steps of administering to a patient through the respiratory route oxygen having helium gas in a predetermined range.

In one case, the oxygen includes the excited oxygen atoms that are absorbed to a greater extent compared to normal oxygen. The oxygen can be bubbled through a solution of methylene blue in water, wherein the solution is irradiated by intense pulsating light of a predetermined wavelength for obtaining the excited oxygen atoms.

For a better understanding of the invention, its operating advantages and the specific objects attained by its uses, reference should be had to the accompanying drawings and descriptive matter in which there is illustrated preferred embodiments of the invention.

